Furthermore, we found that high-risk primary neuroblastoma tumors contain CD68+ tumor-associated monocytes/macrophages (TAMs) producing IL-6 and that bone marrows with neuroblastoma metastases include CD33+ CD14+ monocytic cells, which also express IL-6 [3]. The gene discussed is CD33; the disease is neuroblastoma.